Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas
- 6 May 2020
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 73 (12), 819-825
- https://doi.org/10.1136/jclinpath-2020-206548
Abstract
Aims Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant disorder caused by germline mutations in fumarate hydratase (FH). Affected families have an increased risk of renal cell carcinoma (RCC). HLRCC-associated RCC (HLRCC-RCC) is highly aggressive. Clinicopathological information of genetically diagnosed patients with HLRCC-RCC contributes to the establishment of effective therapies. Methods Ten Japanese patients with HLRCC-RCC were enrolled in the study. Genetic testing for FH was carried out. Somatic mutations in FH and immunohistochemical analyses of FH and B7 family ligands (PD-L1 and B7-H3) were investigated in 13 tumours. Copy number variations were evaluated in two tumours. Results All patients had FH germline mutations. Regarding histology, most tumours had type 2 papillary architecture or tubulocystic pattern or both. All tumours were FH deficient by immunohistochemistry. Ten tumours were positive for PD-L1, and 12 tumours were positive for B7-H3. Somatic mutation analysis demonstrated loss of heterozygosity of FH in 10 tumours. Copy number variation analysis revealed uniparental disomy between 1q24.2 and 1q44 encompassing FH; gain of chromosome 2 p was also common. All patients had either metastases or residual tumours. Three patients died of HLRCC-RCC and one of colon cancer, whereas the other six are currently alive, including two without recurrence. Conclusions HLRCC-RCCs appear to have unique molecular profiles, including PD-L1 expression. One patient had complete response to immunotherapy, which may be an option for HLRCC-RCC.Keywords
This publication has 33 references indexed in Scilit:
- Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal CancerThe American Journal of Surgical Pathology, 2014
- Molecular Pathways: Fumarate Hydratase-Deficient Kidney Cancer—Targeting the Warburg Effect in CancerClinical Cancer Research, 2013
- Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor ActivityClinical Cancer Research, 2012
- Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysisClinical Genetics, 2010
- Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancerGenes, Chromosomes and Cancer, 2009
- The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) SyndromeThe American Journal of Surgical Pathology, 2007
- Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancerJournal of Medical Genetics, 2005
- Mutations in the Fumarate Hydratase Gene Cause Hereditary Leiomyomatosis and Renal Cell Cancer in Families in North AmericaAmerican Journal of Human Genetics, 2003
- Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancerNature Genetics, 2002
- Inherited susceptibility to uterine leiomyomas and renal cell cancerProceedings of the National Academy of Sciences of the United States of America, 2001